IllnessGilbert [Meulengracht] syndrome, unconjugated hyperbilirubinemia
Summary
Exclusive curated analysis of the promotor repeat A(TA)6-7TAA in the UGTA1A gene with suspected Gilbert-[Meulengracht] syndrome
1,7 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
X (UGT1A1 promotor analysis)
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
UGT1A1 | 1602 | NM_000463.3 | AR |
Informations about the disease
In the German-speaking medical world, terms such as Morbus Meulengracht, Meulengracht syndrome or Gilbert-Meulengracht syndrome (German ICD-10 80.4) are often used for a clinical picture that is largely uniformly referred to as "Gilbert syndrome" in other countries. Gilbert syndrome results in benign, chronic, stable or intermittent, unconjugated hyperbilirubinaemia; no structural liver disease or haemolysis is present. Gilbert's syndrome is the most common disorder of bilirubin metabolism in the liver and also often causes neonatal jaundice.
Laboratory data:
Crigler-Najjar syndrome type 1: total serum bilirubin 20-45mg/dL [complete UGT1A1 deficiency].
Crigler-Najjar syndrome type 2: total serum bilirubin 6-20mg/dL [<20% UGT1A1 activity].
DD: Gilbert syndrome/M. Meulengracht: total serum bilirubin 1-6mg/dL [UGT1A1 promoter deficiency].
- Arias syndrome - Crigler-Najjar syndrome 2
- Bilirubin uridinediphosphate glucuronosyltransferase deficiency type 1 [CNS1]/Type 2 [CNS2]
- Bilirubin-UGT deficiency type 1 [Crigler-Najjar syndrome 1]/Type 2 [Crigler-Najjar syndrome 2]
- Crigler-Najjar syndrome, type I (UGT1A1)
- Crigler-Najjar syndrome, type II (UGT1A1)
- Gilbert syndrome (UGT1A1)
- Hereditary unconjugated hyperbilirubinemia type 1 [Crigler-Najjar syndrome 1]/type 2 [CNS2]
- Hyperbilirubinaemia, familial transient neonatal (UGT1A1)
- UGT deficiency type 1 [Crigler-Najjar syndrome 1]/Type 2 [Crigler-Najjar syndrome 2]
- AR
Bioinformatics and clinical interpretation
No text defined